← Leaderboards
Terry A Van Dyke
University Of North Carolina Chapel Hill
$19,016,013
Attributed
$19,016,013
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–09$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$20,025,839 · 13
By mechanism
U01$9,208,992 · 1
R01$7,423,745 · 3
P30$1,471,914 · 2
U42$1,009,826 · 1
U54$509,037 · 1
P01$265,784 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Albert Sidney Baldwin$25,224,800
- Channing J Der$34,774,720
- William K Kaufmann$14,512,029
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseMalignant NeoplasmsGenetically Modified AnimalsGene TargetingNeoplasm /Cancer GeneticsMouse ModelCellsTransgenic OrganismsMutantHuman DiseaseGenetically Engineered MouseTumorNeoplastic ProcessDisease /Disorder ModelTransfection /Expression VectorCostP53 Gene /ProteinAnimalsResearch PersonnelGenesIn VivoMutationGeneticBiological Models
Grant awards (48)
CORE--ANIMAL MODELS$382,580
P30 · FY2009 · CA · contact PI
Mitotic Checkpoint Regulators: Roles in Development and Cancer$367,231
R01 · FY2009 · CA · contact PI
Animal Models Core$121,846
U54 · FY2009 · CA · contact PI
Astrocytic Cancers: How, When, Where?$75,305
U01 · FY2009 · CA · contact PI
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS$46,752
P41 · FY2009 · RR · contact PI
Astrocytic Cancers: How, When, Where?$976,583
U01 · FY2008 · CA · contact PI
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE$479,600
R01 · FY2008 · CA · contact PI
CORE--ANIMAL MODELS$382,996
P30 · FY2008 · CA · contact PI
Mitotic Checkpoint Regulators: Roles in Development and Cancer$357,664
R01 · FY2008 · CA · contact PI
Animal Models Core$115,743
U54 · FY2008 · CA · contact PI
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS$29,268
P41 · FY2008 · RR · contact PI
Astrocytic Cancers: How, When, Where?$1,087,426
U01 · FY2007 · CA · contact PI
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE$474,367
R01 · FY2007 · CA · contact PI
CORE--ANIMAL MODELS$364,928
P30 · FY2007 · CA · contact PI
Mitotic Checkpoint Regulators: Roles in Development and Cancer$355,040
R01 · FY2007 · CA · contact PI
Animal Models Core$113,585
U54 · FY2007 · CA · contact PI
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS$32,559
P41 · FY2007 · RR · contact PI
Astrocytic Cancers: How, When, Where?$1,087,330
U01 · FY2006 · CA · contact PI
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE$474,305
R01 · FY2006 · CA · contact PI
Mitotic Checkpoint Regulators: Roles in Development and Cancer$354,996
R01 · FY2006 · CA · contact PI
CORE--ANIMAL MODELS$173,228
P30 · FY2006 · CA · contact PI
Animal Models Core$80,098
U54 · FY2006 · CA · contact PI
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION$73,000
R01 · FY2006 · CA · contact PI
Astrocytic Cancers: How, When, Where?$1,080,550
U01 · FY2005 · CA
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE$471,578
R01 · FY2005 · CA
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION$363,673
R01 · FY2005 · CA
CORE--ANIMAL MODELS$168,182
P30 · FY2005 · CA
Animal Models Core$77,765
U54 · FY2005 · CA
Astrocytic Cancers: How, When, Where?$850,000
U01 · FY2004 · CA
MECHANISMS OF EPITHELIAL CELL TUMORIGENESIS IN THE MOUSE$457,839
R01 · FY2004 · CA
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION$351,956
R01 · FY2004 · CA
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS$27,962
P41 · FY2004 · RR
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS$1,403,087
U01 · FY2003 · CA
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION$341,704
R01 · FY2003 · CA
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS$1,108,628
U01 · FY2002 · CA
ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS$346,949
R01 · FY2002 · CA
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION$331,751
R01 · FY2002 · CA
Core--Animal$265,784
P01 · FY2002 · HL
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS$906,052
U01 · FY2001 · CA
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS$398,846
R01 · FY2001 · CA
P53 AND ATM CHECKPOINTS IN THYMIC LYMPHOMA SUPPRESSION$349,374
R01 · FY2001 · CA
ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS$336,913
R01 · FY2001 · CA
Core--Animal$0
P01 · FY2001 · HL
A CAROLINA CENTER TO CHARACTERIZE &MAINTAIN MUTANT MICE$1,009,826
U42 · FY2000 · RR
PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS$634,031
U01 · FY2000 · CA
MECHANISM OF LARGE T ANTIGEN INDUCED TUMORIGENESIS$387,228
R01 · FY2000 · CA
ANTI-ANGIOGENESIS GENE THERAPY FOR DE NOVO TUMORS$349,731
R01 · FY2000 · CA
CORE--ANIMAL MODELS$0
P30 · FY2000 · CA